375 related articles for article (PubMed ID: 1572907)
1. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
[TBL] [Abstract][Full Text] [Related]
2. Activation of protein kinase C inhibits human keratinocyte migration.
Ando Y; Lazarus GS; Jensen PJ
J Cell Physiol; 1993 Sep; 156(3):487-96. PubMed ID: 8360256
[TBL] [Abstract][Full Text] [Related]
3. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor dependence and TGF alpha autocrine growth regulation in primary rat tracheal epithelial cells.
Ferriola PC; Robertson AT; Rusnak DW; Diaugustine R; Nettesheim P
J Cell Physiol; 1992 Aug; 152(2):302-9. PubMed ID: 1639864
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of transforming growth factor alpha autoinduction in a nontransformed and transformed epithelial cell.
Coffey RJ; Graves-Deal R; Dempsey PJ; Whitehead RH; Pittelkow MR
Cell Growth Differ; 1992 Jun; 3(6):347-54. PubMed ID: 1419897
[TBL] [Abstract][Full Text] [Related]
6. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
7. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin.
Piazza GA; Ritter JL; Baracka CA
Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633
[TBL] [Abstract][Full Text] [Related]
9. TGF-alpha-driven tumor growth is inhibited by an EGF receptor tyrosine kinase inhibitor.
El-Obeid A; Hesselager G; Westermark B; Nistér M
Biochem Biophys Res Commun; 2002 Jan; 290(1):349-58. PubMed ID: 11779176
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
12. Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.
Zyzak LL; MacDonald LM; Batova A; Forand R; Creek KE; Pirisi L
Cell Growth Differ; 1994 May; 5(5):537-47. PubMed ID: 8049160
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
14. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with vitamin A inhibits transforming growth factor alpha stimulation of human mammary carcinoma cells.
Halter SA; Winnier AR; Arteaga CL
J Cell Physiol; 1993 Jul; 156(1):80-7. PubMed ID: 7686167
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
Okamoto H; Kimura M; Watanabe N; Ogihara M
Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
18. Rieger syndrome revisited: experimental approaches using pharmacologic and antisense strategies to abrogate EGF and TGF-alpha functions resulting in dysmorphogenesis during embryonic mouse craniofacial morphogenesis.
Slavkin HC
Am J Med Genet; 1993 Oct; 47(5):689-97; discussion 687-8. PubMed ID: 8266997
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
Morishige K; Kurachi H; Amemiya K; Fujita Y; Yamamoto T; Miyake A; Tanizawa O
Cancer Res; 1991 Oct; 51(19):5322-8. PubMed ID: 1717146
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of EGF-like growth factor genes in human keratinocytes.
Stoll SW; Elder JT
Biochem Biophys Res Commun; 1999 Nov; 265(1):214-21. PubMed ID: 10548517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
